TheraCUES GeoMx DSP Grant Call

Nanostring in collaboration with Theracues Innovations is offering a Grant for the most deserving researcher who would like to exploit the capabilities of GeoMx® Digital Spatial Profiler (DSP). We are calling for applications, last date for submission is 30th of November

Calling all innovative researchers in India!

Measure biology where it happens.

Understanding tissue heterogeneity is crucial to studying developmental biology, disease pathogenesis, and response to treatment. Bridging the gap between tissue imaging and molecular profiling technologies such as single-cell analysis, the GeoMx® Digital Spatial Profiler (DSP) allows you to unlock novel biological insights with spatial multiomics.

  • Revolutionize your understanding of tissue heterogeneity in development or disease by measuring the biology where it happens.
  • Whole transcriptome profiling of cell types in situ without the need to disrupt or destroy tissue samples.
  • Develop new combinational therapeutic strategies based on data driven molecular analysis of tissue heterogeneity in precious clinical samples.
  • Define new biomarkers and gene signatures associated with discrete regions or cell populations in the tissue.
  • Flexible input. Analyse whole tissue slices or multiple samples as tissue microarrays.

Application Deadline: Thursday, November 30, 2023

Two Winners -Each will get an opportuinity to experience GeoMx Digital Spatial Profiler services from TheraCUES, an exclusive Nanostring service provider at Bengaluru, India (https://theracues.com)

  • 1 slide worth of the GeoMx DSP whole transcriptomics data with the WTA/CTA (Human or Mouse) panel with Commercially available morphology kit for tissue staining
  • Whole tissue on the slide or multi-tissue sample (TMA)
  • Maximum of 12 AOI /slide
  • Illumina Sequencing read data from 12 AOI/slide
  • Project planning and data analysis consultation

Two Runners -Each will receive: Following services at 50% Discount: an exclusive Nanostring service provider at Bengaluru, India

  • 1 slide worth of the GeoMx DSP whole transcriptomics data with the the WTA/CTA (Human or Mouse) panel with Commercially available morphology kit for tissue staining
  • Whole tissue on the slide or multi-tissue sample (TMA)
  • Maximum of 12 AOI /slide
  • Illumina Sequencing read data from 12 AOI/slide
  • Project planning and data analysis consultation

Grant Details:

Open to all researchers within India.

NanoString will award 2 most impactful proposal with the ability to discover spatial biomarkers, study tissue heterogeneity and spatial gene expression, or study cell-type specific questions using the GeoMx® Whole Transcriptome Atlas (WTA). (Human and Mouse only) or GeoMx Cancer Transcriptome Atlas (CTA)

Comprehensive, unbiased RNA content for human, mouse, and canine: Explore any target and any pathway in biological regions of interest. The GeoMx Whole Transcriptome Atlas (WTA) provides an unbiased view of 18,000+ (Human) or 21,0000+ (Mouse) protein-coding genes. With CTA one can profile 1800+ (Human) comprehensive tumor related protein-coding genes.

Sample types: FFPE, OCT embedded and Fresh Frozen. (Human and Mouse Only)

NanoString standard morphology markers or H&E staining: Fluorescently-labeled morphology markers are used for the visualization of tissue morphology, the selection of regions of interest (ROI), and the segmentation of ROIs into distinct biological compartments, or areas of interest (AOI). The winner will receive 1 slide worth data from 12 AOI events for the GeoMx WTA/CTA Assay, to be agreed upon following project discussions with NanoString/Theracues.

Data analysis support: The GeoMx DSP data center provides an end-to-end software solution from image acquisition and region of interest selection to a fully integrated data analysis experience. Questions before getting started? Reach out to one of our in-house experts support@nanostring.com

Publication of Project Results:

Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and each winner: webinar, case study, blog post, or poster presentation. Each winner agrees that NanoString shall have the right to publicly announce the winner’s name and research topic and use anonymized data from the winner’s project in application notes including in marketing materials and seminars.

Eligibility and Requirements:

Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research and have the ability to ship samples by 15 December2023. The winner must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program. The grant winner will provide 1 slide to be used with the GeoMx® Whole Transcriptome Atlas RNA run through TheraCUES.

Miscellaneous:

By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All grant applicants agree that NanoString may process the personal data he or she provides as part of application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at nanostring.com/privacy. The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded grant is allowed, except as otherwise permitted by NanoString. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.